New disease severity classification of patients with stable chronic obstructive pulmonary disease in Shanghai

被引:4
|
作者
Xie Guogang [1 ]
Zhang Yingying [1 ]
Zhou Xin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Resp Med, Shanghai 200080, Peoples R China
关键词
chronic obstructive pulmonary disease; Global Initiative for Chronic Obstructive Lung Disease; chronic obstructive pulmonary disease assessment test; exacerbation; lung function test; HEALTH-STATUS; LUNG-FUNCTION; COPD; EXACERBATION; PREDICTION; PROPIONATE; DECLINE; COHORT;
D O I
10.3760/cma.j.issn.0366-6999.20141206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The Global Initiative for Chronic Obstructive Lung Disease (GOLD) presented a new ABCD group classification of chronic obstructive pulmonary disease (COPD). We aimed to examine the association of spirometric classification and the new GOLD classification with exacerbations, and to compare symptoms in different ways. Methods We investigated 848 patients with stable COPD from 24 hospitals. The annual frequencies of acute exacerbation and hospitalization were compared between the old and new classification. The symptom level was assessed using COPD assessment test (CAT) and modified British Medical Research Council (mMRC) questionnaire. Results A total of 848 patients were included in this study. According to spirometric classification, there were 32 patients of grade I (3.8%), 315 of grade II (37.1%), 366 of grade III (43.2%), and 135 of grade IV (15.9%). According to GOLD 2011 classification, there were 59 patients of group A (7.0%), 172 of group B (20.3%), 55 of group C (6.5%), and 562 of group D (66.3%). In spirometric classification, the annual frequencies of acute exacerbation and associated hospitalization were respectively 1 (0-3) and 0 (0-2) for grade I; 1 (0-5) and 0 (0-2) for grade II; 2 (0-6) and 1 (0-3) for grade III, and 3 (0-6) and 2 (0-3) for grade IV. In GOLD 2011, respectively 0 (0-3) and 0 (0-1) (group A), 1 (0-4) and 0 (0-3) (group B), 1 (0-5) and 0 (0-3) (group C), and 3 (0-6) and 1 (0-3) (group D). There were no significant difference between group B and C (Z=similar to 1.347, P=0.178; Z= -0.772, P=0.440, respectively). The coincidence rate using mMRC=1 and CAT=10 as cutoff points was 86.6% (734/848, kappa=0.706), compared with 77.9% (661/848, kappa=0.60) using mMRC=2 and CAT=10. Conclusions Lung function test may be a better predictor of acute exacerbation and associated hospitalization of COPD. It is more appropriate to use mMRC=1 as cutoff point for assessing COPD symptoms.
引用
收藏
页码:3046 / 3050
页数:5
相关论文
共 50 条
  • [41] Health status and chronic obstructive pulmonary disease severity
    Antoniu, Sabina A.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (04) : 399 - 401
  • [42] Markers of exacerbation severity in chronic obstructive pulmonary disease
    Franciosi, Luigi G.
    Page, Clive P.
    Celli, Bartolome R.
    Cazzola, Mario
    Walker, Michael J.
    Danhof, Meindert
    Rabe, Klaus F.
    Della Pasqua, Oscar E.
    RESPIRATORY RESEARCH, 2006, 7 (1)
  • [43] Chronic obstructive pulmonary disease severity and cardiovascular outcomes
    Suellen M. Curkendall
    Stephan Lanes
    Cynthia de Luise
    Mary Rose Stang
    Judith K. Jones
    Dewei She
    Earl Goehring
    European Journal of Epidemiology, 2006, 21 : 803 - 813
  • [44] Markers of exacerbation severity in chronic obstructive pulmonary disease
    Luigi G Franciosi
    Clive P Page
    Bartolome R Celli
    Mario Cazzola
    Michael J Walker
    Meindert Danhof
    Klaus F Rabe
    E Della Oscar Pasqua
    Respiratory Research, 7
  • [45] Chronic obstructive pulmonary disease -: 4:: Imaging the lungs in patients with chronic obstructive pulmonary disease
    Müller, NL
    Coxson, H
    THORAX, 2002, 57 (11) : 982 - 985
  • [46] Chronic obstructive pulmonary disease severity and cardiovascular outcomes
    Curkendall, Suellen M.
    Lanes, Stephan
    de Luise, Cynthia
    Stang, Mary Rose
    Jones, Judith K.
    She, Dewei
    Goehring, Earl, Jr.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 (11) : 803 - 813
  • [47] Pneumonia in the patient with chronic obstructive pulmonary disease.: Levels of severity and risk classification
    de Oña, JMR
    Fernández, MG
    Celdrán, J
    Puente-Maestu, L
    ARCHIVOS DE BRONCONEUMOLOGIA, 2003, 39 (03): : 101 - 105
  • [48] Chronic obstructive pulmonary disease exacerbation frequency and severity
    Stafyla, Eirini
    Kerenidi, Theodora
    Gourgoulianis, Konstantinos I.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 : 533 - 534
  • [49] New Modalities of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease
    Martijn A. Spruit
    Emiel F. M. Wouters
    Sports Medicine, 2007, 37 : 501 - 518
  • [50] An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations The Rome Proposal
    Celli, Bartolome R.
    Fabbri, Leonardo M.
    Aaron, Shawn D.
    Agusti, Alvar
    Brook, Robert
    Criner, Gerard J.
    Franssen, Frits M. E.
    Humbert, Marc
    Hurst, John R.
    O'Donnell, Denis
    Pantoni, Leonardo
    Papi, Alberto
    Rodriguez-Roisin, Roberto
    Sethi, Sanjay
    Torres, Antoni
    Vogelmeier, Claus F.
    Wedzicha, Jadwiga A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (11) : 1251 - 1258